Open Orphan PLC (ORPH)

10.85
-0.40(-3.56%)
  • Volume:
    842,348
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    10.85 - 10.85

ORPH Overview

Prev. Close
11.25
Day's Range
10.85-10.85
Revenue
36.87M
Open
11.25
52 wk Range
10.55-32.5
EPS
0
Volume
842,348
Market Cap
73.74M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,544,585
P/E Ratio
-
Beta
1.6
1-Year Change
-64.84%
Shares Outstanding
670,929,314
Next Earnings Date
18 Sept 2022
What is your sentiment on Open Orphan?
or
Market is currently closed. Voting is open during market hours.

Open Orphan PLC News

Open Orphan PLC Company Profile

Open Orphan PLC Company Profile

Open Orphan Plc is a United Kingdom-based Contract Research Organisation (CRO) pharmaceutical services company. The Company is engaged in the testing of vaccines and antivirals using human clinical trials. The Company has a presence in the United Kingdom, Ireland, France and Netherlands. The Company, through its subsidiary hVIVO Limited, is also engaged in the data platform business. hVIVO Limited has built up databases of infectious disease progression data and the Company is populating its Open Orphan Health Data platform with hVIVO data. The Company also operates through its subsidiary Venn Life Sciences, which is an integrated drug development partner. Venn Life Sciences offers a combination of drug development consultancy, clinical trial design and execution to create, plan and execute drug development programs for its customers.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Great news! Huge potential. Buying opportunity IMO DYOR
    1
    • Excellent presentation by Executive Chairman 11/6/20: https://www.openorphan.com/sites/openorphan-v2/files/2020-06/Open_Orphan_Investor_Presentation-June_2020_3.pdf HUGE  potential. DYOR!
      0
      • Open Orphan launches “best-in-class" coronavirus testing service 2020-06-04 07:53:00
        0
        • whats goin on
          0
      • Nigel i do like ORPH but i think they are a little to far behind the likes of Genedrive,and today they have the  CE Mark to start selling to the world.Plus ORPH have just had a Placing which will hold them back as it did with Gnedrive 2 weeks ago. good luck
        1
        • Cheers Paul i think it is interesting times for both companies .I still dont think folk understand what ORPH are about
          0
      • i looked at them but genedrive got my vote after many hours of research
        0
        • Interesting Paul ,good luck
          0
        • Paul i think ORPH is a sleeping giant.
          0
        • Good morning Paul any views on share price .Genedrive on my radar .
          0
      • Anybody following ORPH
        1